DCSIMG
References | PreventDVT.org
For U.S. Residents Only
  Print Print     Text:
Small Text
Medium Text
Large Text

1. Gerotziafas GT, Samama MM. Prophylaxis of venous thromboembolism medical patients. CurrOpin PulmMed. 2004; 10:356-365.

2. American Public Health Association. Presented at: Public Health Leadership Conference on Deep-Vein Thrombosis: February 26, 2003: Washington, D.C. White Paper.

3. National, Heart, Lung and Blood Institute. How Is Deep Vein Thrombosis Diagnosed? Available at http://www.nhlbi.nih.gov/health/dci/Diseases/Dvt/DVT_Diagnosis.html (accessed September 15, 2009).

4. American Academy of Orthopaedic Surgeons (June 2001). Deep Vein Thrombosis. Retrieved August 24, 2007, from the American Academy of Orthopaedic Surgeons Web site: http://orthoinfo.aaos.org/fact/thr_report.cfm?Thread_ID=264.

5. Heit et al. Am Soc Hematol. Presented a: 47th Annual Meeting and Exposition, American Society of Hematology; December 2005; Atlanta GA, Poster [68].

6. Geerts WH, Pineo GF, Heit JA et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest.2004; 126(suppl): 338S-400S.

7. Goldhaber SZ. Deep vein thrombosis: advancing awareness to protect patient lives. White paper. American Public Health Association; Public Health Leadership Conference: Washington, DC: February 26, 2003.

8. Spencer FA, Lessard D, Emery C et.al. Venous Thromboembolism in the Outpatient Setting. Arch Intern Med/Vol (NO. 14), July 23, 2007.

9. Murin et al. Thromb Haemost. Comparison of the Outcomes after Hospitalization for Deep Venous Thrombosis or Pulmonary Embolism. 2002; 88:407-14.

10. Gerotziafas GT, Samama MM. Prophylaxis of venous thromboembolism medical patients. CurrOpin PulmMed. 2004; 10:356-365.

11. The National Alliance for Thrombosis and Thrombophila. Postthrombotic Syndrome (Venous Stress Disorder): An Indepth Guide for patients and health care providers. Available at http://www.stoptheclot.org/natt_publications/post_thrombotic_syndrome.pdf (Accessed September 16, 2009).

12. About.com. How the Blood Clots; How to Prevent Abnormal Clotting. Available at http://heartdisease.about.com/cs/heartattacks/a/clotting_3.htm (Accessed September 15, 2009).

13. Geerts WH, Pineo GF, Heit JA et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest.2004; 126(suppl): 338S-400S.

14. Mayo Clinic. Complications. Available at http://www.mayoclinic.com/health/deep-vein-thrombosis/DS01005/DSECTION=6 [Accessed September 8, 2009].

15. Vascular Disease Foundation. Frequently Asked Questions. Available at http://www.vdf.org/diseaseinfo/dvt/faqs.php [Accessed September 15,2009].

16. Clot Care Online Resource. What is the d-Dimer test? Available at: http://www.clotcare.com/clotcare/faq_ddimertest.aspx [Accessed September 15,2009].

17. Heit JA. Venous thromboembolism epidemiology. Semin Thromb Hemost. 2002;28(suppl 2):3-13.

18. DeSancho et al. Bleeding and Thrombotic Complications in Critically Ill Patients with Cancer. Critical Care Clinics. 2001: 17:599-622.

19. Maiocco, Gina. DVT Prevention for the Obese Patient: Evidence-based Nurisng Interventions. Bariatric Nursing and Surgical Patient Care, Vol. 3, No. 4 2008: 279-284.

20. Zoller B, Hillarp A, Berntorp E, Dahlback B. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis. Annual Review of Medicine 1997; 48: 45-58.

21. Vacular Disease Foundation. Focus on Blood Clots. Venous Thromboembolism(VTE): What you need to know about risk factors, symptoms and treatment . [Accessed September 28, 2009].

22. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJM III. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809-815.

23. Agency for Healthcare Research and Quality (AHRQ). Appendix A: Talking Points to Attract Administration Support for Venous Thromboembolism Prevention Programs. Hospitalized patients are at high risk for venous thromboembolism (VTE). Available at http://www.ahrq.gov/qual/vtguide/vtguideapa.htm [Accessed September 8, 2009].

24. Centers for Disease Control and Prevention (CDC). Are You At Risk for Deep Vein Thrombosis? Available at http://www.cdc.gov/Features/Thrombosis (accessed September 8, 2009).

25. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute. High Blood Cholesterol: What You Need To Know. Revised June 2005. Available at http://www.nhlbi.nih.gov/health/public/heart/chol/wyntk.htm (Accessed September 15, 2009).

26. U.S. Department of Human Services. Agency for Healthcare Research and Quality. Effects of Soy on Health Outcomes. Available at http://www.ahrq.gov/Clinic/epcsums/soysum.htm (accessed September 15, 2009).

27. American Heart Association (AHA). Fiber AHA Recommendation. Available at http://www.americanheart.org/presenter.jhtml?identifier=4574 (accessed September 15, 2009).

28. American Heart Association (AHA). Fiber AHA Recommendation. Available at http://www.americanheart.org/presenter.jhtml?identifier=4632 (accessed September 15, 2009).

29. Lee, A.Y., et al. (2003) “Low-Molecular-Weight Heparin vs. Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer: Randomized Comparison of Low-Molecular-Weight Heparin vs. Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer.” New England Journal of Medicine 349:146-153.

30. Lynman, Gary H. et.al. American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer. J Clin Oncol 25:5490-5505.

31. American Heart Association. Common Cardiovascular Diseases. Available at http://www.americanheart.org/ presenter.jhtml?identifier=2873 (Accessed September 8, 2009).

32. American Heart Association. Risk Factors and Coronary Artery Disease. Available at http://www.americanheart.org/ presenter.jhtml?identifier=4726 (Accessed September 8, 2009).

33. Office of the Surgeon General. The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Available at http://sg.cit.nih.gov/topics/deepvein/calltoaction/call-to-action-on-dvt-2008.pdf [Accessed September 2, 2009].

34. Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2009 Mar;135(3):786-93.

35. Agency for Healthcare Research and Quality (AHRQ). National Healthcare Disparities Report, 2003 Summary. Available at http://www.ahrq.gov/qual/nhdr03/nhdrsum03.htm. [Accessed September 8, 2009].

36. Galson, Steven K. Public Health Reports. Surgeon General Perspectives. July-August 2008; Vol. 123.

37. US Department of Commerce. US Census Bureau News. US Hispanic population surpasses 45 million. Now 15 of total. http://www.censusbureau.gov/press-release/www/releases/archives/population/011910.html.Accessed July 28, 2008.

Are you or a loved one at risk for DVT blood clots?

Key DVT Statistics

Did you know that up to 2 million Americans are affected annually by DVT?